Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (51 quarters reported)
$256M in Q4 2013 → $1.06B now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| UH United Health Group Inc | 3.7% | Added 106% | 93,600 | $38.9M |
| Cvs Health Corp | 2.7% | Trimmed 17% | 279,374 | $28.9M |
| Astrazeneca PLC | 2.7% | New | 151,500 | $28.5M |
| Merck & Co Inc | 2.6% | New | 213,500 | $27.4M |
| LE Lilly Eli & Co | 2.5% | Trimmed 34% | 22,315 | $26.8M |
| Abbvie Inc | 2.3% | Added 35% | 96,775 | $24.4M |
| Alignment Healthcare Inc | 2.2% | Trimmed 5.4% | 997,083 | $23.7M |
| Edwards Lifesciences Corp | 2.2% | Added 60% | 260,000 | $23.5M |
| Gilead Sciences Inc | 2.1% | Added 6.3% | 178,250 | $22.5M |
| Jazz Pharmaceuticals PLC | 2.0% | Added 15% | 87,440 | $21.1M |
| Biogen Inc | 1.9% | Trimmed 13% | 94,850 | $20.5M |
| Stryker Corporation | 1.9% | Added 36% | 65,000 | $20.5M |
| Boston Scientific Corp | 1.8% | Trimmed 28% | 450,500 | $19.2M |
| Johnson & Johnson | 1.7% | New | 72,500 | $18.4M |
| Guardant Health Inc | 1.6% | Trimmed 21% | 115,000 | $17.3M |
| Regeneron Pharmaceuticals | 1.6% | Trimmed 43% | 27,390 | $17.1M |
| Glaukos Corp | 1.6% | Added 42% | 119,000 | $16.6M |
| Biomarin Pharmaceutical Inc | 1.6% | Added 40% | 290,500 | $16.6M |
| Nurix Therapeutics Inc | 1.6% | Added 118% | 684,250 | $16.6M |
| Natera Inc | 1.6% | Added 18% | 61,050 | $16.6M |
| Mirum Pharmaceuticals Inc | 1.5% | Added 50% | 139,205 | $16.3M |
| Insmed Inc | 1.5% | Trimmed 4.9% | 151,960 | $16.2M |
| Tenet Healthcare Corp | 1.5% | Added 58% | 85,200 | $15.9M |
| Thermo Fisher Scientific Inc | 1.5% | Trimmed 24% | 31,580 | $15.8M |
| CD Centene Corp Del | 1.5% | New | 244,000 | $15.7M |
| Axsome Therapeutics Inc. | 1.5% | Trimmed 1.2% | 63,050 | $15.4M |
| Danaher Corporation | 1.4% | Added 345% | 80,252 | $15.3M |
| Vertex Pharmaceuticals Inc | 1.4% | Trimmed 29% | 30,685 | $15.2M |
| Anteris Technologies Global | 1.4% | Added 7.0% | 1,538,625 | $15.2M |
| Neurocrine Biosciences Inc | 1.4% | Trimmed 15% | 85,841 | $14.5M |
| Pennant Group Inc | 1.3% | Added 35% | 371,471 | $13.7M |
| Intuitive Surgical Inc | 1.3% | Trimmed 6.4% | 34,500 | $13.7M |
| Elevance Health Inc | 1.3% | Added 8.0% | 34,900 | $13.5M |
| Livanova PLC | 1.3% | Added 5.8% | 164,000 | $13.5M |
| Cencora Inc | 1.2% | Trimmed 11% | 46,778 | $13.2M |
| CR Charles Riv Labs Intl Inc | 1.2% | Added 120% | 57,200 | $13M |
| Ideaya Biosciences Inc | 1.2% | Added 35% | 343,800 | $12.8M |
| Mckesson Corp | 1.2% | Trimmed 1.8% | 16,550 | $12.5M |
| Syndax Pharmaceuticals Inc | 1.2% | Added 48% | 560,250 | $12.2M |
| BH Brightspring Health Svcs Inc | 1.1% | Added 232% | 165,896 | $11.6M |
| Medtronic PLC | 1.1% | Added 61% | 145,000 | $11.3M |
| Mineralys Therapeutics Inc | 1.1% | Added 58% | 416,371 | $11.2M |
| Oscar Health Inc | 1.1% | Trimmed 41% | 392,000 | $11.2M |
| Royalty Pharma PLC | 1.0% | Trimmed 15% | 197,000 | $11M |
| Dexcom Inc | 1.0% | New | 160,000 | $10.8M |
| Align Technology Inc | 1.0% | Added 740% | 63,000 | $10.6M |
| Spyre Therapeutics Inc | 1.0% | New | 119,300 | $10.6M |
| Relay Therapeutics Inc | 1.0% | Added 57% | 566,000 | $10.6M |
| AP Arrowhead Pharmaceuticals In | 1.0% | Trimmed 11% | 128,000 | $10.4M |
| Agilent Technologies Inc | 0.9% | Added 200% | 75,000 | $9.96M |
| Nektar Therapeutics | 0.9% | Added 139% | 141,250 | $9.86M |
| Alkermes PLC | 0.9% | Added 39% | 185,250 | $9.71M |
| Abbott Laboratories | 0.8% | Trimmed 14% | 96,000 | $8.71M |
| Dianthus Therapeutics Inc | 0.8% | Added 5.5% | 86,127 | $8.4M |
| Procept Biorobotics Corp | 0.7% | Trimmed 27% | 345,000 | $7.79M |
| Structure Therapeutics Inc | 0.7% | Added 13% | 145,100 | $7.79M |
| Oruka Therapeutics Inc | 0.7% | New | 80,000 | $7.61M |
| Encompass Health Corp | 0.7% | Added 32% | 74,263 | $7.51M |
| Moonlake Immunotherapeutics | 0.7% | Added 61% | 384,800 | $7.49M |
| Iovance Biotherapeutics Inc | 0.7% | Trimmed 17% | 1,705,327 | $7.09M |
Showing top 60 of 99 positions.
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended June 30, 2026 · filed August 13, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Astrazeneca PLC | New | +151,500 | +$28.5M | 2.7% |
| Merck & Co Inc | New | +213,500 | +$27.4M | 2.6% |
| UH United Health Group Inc | Added | +48,100 | +$20M | 3.7% |
| Johnson & Johnson | New | +72,500 | +$18.4M | 1.7% |
| CD Centene Corp Del | New | +244,000 | +$15.7M | 1.5% |
| LE Lilly Eli & Co | Trimmed | −11,400 | −$13.7M | 2.5% |
| Regeneron Pharmaceuticals | Trimmed | −20,710 | −$12.9M | 1.6% |
| VS Veeva Sys Inc | Trimmed | −68,000 | −$12.1M | 0.3% |
| Danaher Corporation | Added | +62,200 | +$11.8M | 1.4% |
| Dexcom Inc | New | +160,000 | +$10.8M | 1.0% |
Showing the 10 largest of 104 changes.
quarter ended March 31, 2026 · filed May 14, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Vera Therapeutics Inc | Exited | −420,000 | −$21.3M | — |
| CC Cooper Cos Inc | Trimmed | −277,500 | −$19.8M | 0.4% |
| Medtronic PLC | Trimmed | −206,000 | −$17.8M | 1.0% |
| Stryker Corporation | New | +47,800 | +$15.7M | 1.9% |
| Align Technology Inc | Trimmed | −91,500 | −$15.7M | 0.2% |
| Danaher Corporation | Trimmed | −81,000 | −$15.4M | 0.4% |
| VS Veeva Sys Inc | New | +85,300 | +$15M | 1.8% |
| Glaukos Corp | Trimmed | −126,000 | −$13.6M | 1.1% |
| Boston Scientific Corp | Added | +193,793 | +$12.2M | 4.8% |
| Abbott Laboratories | New | +112,000 | +$11.5M | 1.4% |
Showing the 10 largest of 102 changes.
quarter ended December 31, 2025 · filed February 13, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Regeneron Pharmaceuticals | Added | +25,300 | +$19.5M | 4.4% |
| Exact Sciences Corp | Exited | −348,000 | −$19M | — |
| Cardinal Health Inc | Exited | −94,000 | −$14.8M | — |
| Vera Therapeutics Inc | Added | +290,000 | +$14.7M | 2.0% |
| Cytokinetics Inc | Trimmed | −210,875 | −$13.4M | 0.3% |
| AL Abbott Labs | Exited | −98,500 | −$13.2M | — |
| LE Lilly Eli & Co | Trimmed | −11,200 | −$12M | 4.2% |
| Ionis Pharmaceuticals Inc | Trimmed | −151,500 | −$12M | 1.2% |
| Amgen Inc | New | +36,000 | +$11.8M | 1.1% |
| Nuvalent Inc | Added | +110,850 | +$11.2M | 1.5% |
Showing the 10 largest of 99 changes.
quarter ended September 30, 2025 · filed November 13, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Tenet Healthcare Corp | Trimmed | −78,000 | −$15.8M | 1.3% |
| Abbvie Inc | Added | +61,000 | +$14.1M | 3.3% |
| Dexcom Inc | Exited | −159,500 | −$13.9M | — |
| Boston Scientific Corp | Added | +142,000 | +$13.9M | 4.7% |
| Hca Healthcare Inc | Exited | −29,778 | −$11.4M | — |
| UH United Health Group Inc | Added | +32,100 | +$11.1M | 2.4% |
| Verona Pharma PLC | Exited | −106,500 | −$10.1M | — |
| Axsome Therapeutics Inc | Added | +82,000 | +$9.96M | 2.3% |
| Gilead Sciences Inc | Trimmed | −88,000 | −$9.77M | 1.0% |
| Thermo Fisher Scientific Inc | Added | +18,900 | +$9.17M | 1.6% |
Showing the 10 largest of 93 changes.
quarter ended June 30, 2025 · filed August 13, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Bristol-myers Squibb Co | Exited | −325,000 | −$19.8M | — |
| Danaher Corporation | Added | +79,500 | +$15.7M | 3.0% |
| Oscar Health Inc | Trimmed | −710,651 | −$15.2M | 0.8% |
| Procept Biorobotics Corp | Trimmed | −258,000 | −$14.9M | 1.4% |
| UH United Health Group Inc | Trimmed | −47,000 | −$14.7M | 1.2% |
| Mckesson Corp | Trimmed | −19,500 | −$14.3M | 2.6% |
| Molina Healthcare Inc | Trimmed | −46,000 | −$13.7M | 0.8% |
| Natera Inc | Trimmed | −81,000 | −$13.7M | 1.2% |
| LE Lilly Eli & Co | Added | +16,120 | +$12.6M | 5.7% |
| Humana Inc | Exited | −46,830 | −$12.4M | — |
Showing the 10 largest of 92 changes.
quarter ended March 31, 2025 · filed May 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Glaukos Corp | Added | +233,469 | +$23M | 3.1% |
| Merck & Co. Inc | Trimmed | −244,500 | −$21.9M | 0.3% |
| IM Inspire Med Sys Inc | Trimmed | −134,041 | −$21.4M | 0.3% |
| Bristol-myers Squibb Co | New | +325,000 | +$19.8M | 2.3% |
| The Cigna Group | Trimmed | −50,185 | −$16.5M | 1.1% |
| IT Intra-cellular Therapies Inc | Exited | −176,000 | −$14.7M | — |
| Boston Scientific Corp | Trimmed | −144,000 | −$14.5M | 3.5% |
| Elevance Health Inc | Added | +25,800 | +$11.2M | 2.4% |
| Molina Healthcare Inc | Added | +34,000 | +$11.2M | 2.6% |
| Dexcom Inc | New | +155,000 | +$10.6M | 1.2% |
Showing the 10 largest of 97 changes.
quarter ended December 31, 2024 · filed February 13, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Natera Inc | Trimmed | −107,590 | −$17M | 2.0% |
| BD Becton Dickinson & Co | Trimmed | −64,600 | −$14.7M | 1.1% |
| Zimmer Biomet Holdings Inc | New | +124,000 | +$13.1M | 1.3% |
| Boston Scientific Corp | Trimmed | −146,000 | −$13M | 4.1% |
| Hca Healthcare Inc | Trimmed | −41,850 | −$12.6M | 1.1% |
| Glaukos Corp | Trimmed | −74,469 | −$11.2M | 0.6% |
| CC Cooper Cos Inc | Trimmed | −113,000 | −$10.4M | 1.1% |
| Gilead Sciences Inc | Trimmed | −111,000 | −$10.3M | 2.4% |
| The Cigna Group | Added | +36,700 | +$10.1M | 2.2% |
| Elevance Health Inc | Trimmed | −27,350 | −$10.1M | 0.9% |
Showing the 10 largest of 90 changes.
quarter ended September 30, 2024 · filed November 13, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IM Inspire Med Sys Inc | Added | +105,000 | +$22.2M | 2.1% |
| Exact Sciences Corp | Added | +320,000 | +$21.8M | 2.6% |
| UH United Health Group Inc | Trimmed | −32,600 | −$19.1M | 3.4% |
| Elevance Health Inc | Trimmed | −35,300 | −$18.4M | 2.1% |
| Medtronic PLC | Added | +160,000 | +$14.4M | 2.7% |
| NA Novo-nordisk A S | New | +100,000 | +$11.9M | 1.0% |
| Cvs Health Corp | New | +184,000 | +$11.6M | 0.9% |
| Oscar Health Inc | Trimmed | −535,464 | −$11.4M | 2.4% |
| The Cigna Group | Trimmed | −32,486 | −$11.3M | 1.2% |
| Gilead Sciences Inc | Added | +128,000 | +$10.7M | 2.5% |
Showing the 10 largest of 92 changes.
Loading...
